IVA337
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IVA337, covering 2019-03-04 to 2021-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b Study in NASH to Assess IVA337 [Phase 2]